Key Record Dates
ClinicalTrials.gov Identifier: | NCT03453619 |
---|---|
Brief Title: | Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies |
First Submitted : | February 27, 2018 |
First Submitted that Met QC Criteria : | February 27, 2018 |
First Posted : | March 5, 2018 |
Certification/Extension First Submitted : | August 27, 2020 |
Certification/Extension First Submitted that Met QC Criteria : | August 27, 2020 |
Certification/Extension First Posted : | September 2, 2020 |
Last Update Submitted that Met QC Criteria : | August 27, 2020 |
Last Update Posted : | September 2, 2020 |